Apontis Pharma aus Monheim am Rhein hat sich insbesondere auf die Indikationen Herz-Kreislauf-Erkrankungen, Atemwegserkrankungen sowie Diabetes spezialisiert. Die Wurzeln gehen zurück auf die frühere Schwarz Pharma. Der Börsengang erfolgte im Mai 2021.
COMPANY
INVESTOR TERMSHEET
APPH/D
Apontis Pharma
#BGFL Mood:
Negative
·
#BGFL-Indicator:
Reduce
·
Review date:
16.10.2024
LEI:
894500ETO1J6MR8PDF91
SECTOR:
Gesundheit
SUB-SECTOR:
Pharma
Apontis Pharma
A3CMGM
DE000A3CMGM5
APPH
Xetra
The basic chart view shows the price movement of Apontis Pharma. If you are interested in additional analysis switch to the advanced chart view.
Visualisation of financial information has been one of boersengefluester.de's (BGFL) favourite disciplines from the very beginning. For this reason, we also put a lot of effort into maintaining our own database and have developed numerous analysis tools and key figure tables on this basis.
Even hardened fundamentalists probably look at the chart of a share before they start analysing it in any other way. Accordingly, boersengefluester.de (BGFL) has also developed a wide range of apps relating to chart technology and sophisticated scorings with technical chart components.
boersengefluester.de · #BGFL
· © 2024
The news manufactory
Good luck with all your investments
Founded in 2013 by Gereon Kruse, the financial portal boersengefluester.de is all about German shares - with a clear focus on second-line stocks. In addition to traditional editorial articles, the site stands out in particular thanks to a large number of self-developed analysis tools. All tools are based on a completely self-maintained database for more than 650 shares. As a result, boersengefluester.de produces Germany's largest profit and dividend forecast.
Contact
Idea & concept: 3R Technologies
boersengefluester.de GmbH
Copyright © 2024
by Gereon Kruse
#BGFL